News

IMUNON Announces IMNN-001 Abstract Accepted for Oral Presentation at 2025 ASCO Annual Meeting
Highly promising survival data from OVATION 2 Study of treatment of newly diagnosed advanced ovarian cancer to be presented Initiation of Phase 3 trial sites underway for pivotal study of IMNN-001 ...
Taiwan News4d
Europe CRISPR Gene Editing Market (CAGR) projected at 27.3%, Cultural Exploration Ethnography’s Influence on Consumer Insights
Market Overview: The European CRISPR gene editing market has experienced significant expansion, driven by advancements in biotechnology and increasing investment in genetic research. With a compound ...
Taiwan News4d
Global CRISPR Gene Editing Market CAGR of 26.4%, Unmasking Motivations Ethnography’s Value in Understanding Behavior
The CRISPR gene editing technology has revolutionized the field of molecular biology, offering unprecedented precision and efficiency in genetic manipulation. With its vast potential in various ...
PharmiWeb6d
Global Plasmid DNA Manufacturing Market to Reach USD 10.67 Billion by 2033: Key Insights, Growth Drivers, and Challenges
IntroductionThe Global Plasmid DNA Manufacturing Market is poised for significant growth, with a valuation of USD 2.13 ...
The Manila Times6d
Porton Advanced's End-to-End CDMO Solutions Accelerates IND Approval of Tasly's Innovative Dual-Targeting CAR-T Therapy
Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD's Innovative Dual-Targeting CAR-T Therapy, 'P134 Cell Injection,' which has received Investigational New Drug (IND) ...
Addgene Adds Science and Tech Leaders to Its Management Team and Board of Directors
Addgene is thrilled to have the expertise of this group of leaders in life sciences and technology as part of our management team and Board of Directors – a testament to the value of our vision for a ...